556 filings
Page 2 of 28
8-K/A
STAB
Statera Biopharma, Inc.
22 Sep 22
Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting firm
6:49pm
8-K
STAB
Statera Biopharma, Inc.
8 Sep 22
Entry into a Material Definitive Agreement
6:55pm
8-K
STAB
Statera Biopharma, Inc.
3 Aug 22
Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting firm
2:59pm
8-K
STAB
Statera Biopharma, Inc.
22 Jun 22
Departure of Directors or Certain Officers
3:58pm
8-K
STAB
Statera Biopharma, Inc.
6 Jun 22
Departure of Directors or Certain Officers
4:52pm
8-K
STAB
Statera Biopharma, Inc.
27 May 22
Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing
5:16pm
8-K
STAB
Statera Biopharma, Inc.
27 Apr 22
Departure of Directors or Certain Officers
5:14pm
8-K
STAB
Statera Biopharma, Inc.
18 Apr 22
Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to Entolimod
4:55pm
8-K
STAB
Statera Biopharma, Inc.
15 Apr 22
Changes in Registrant's Certifying Accountant
5:14pm
8-K/A
STAB
Statera Biopharma, Inc.
13 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:22am
8-K
STAB
Statera Biopharma, Inc.
31 Mar 22
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:08pm
NT 10-K
STAB
Statera Biopharma, Inc.
31 Mar 22
Notice of late annual filing
4:07pm
8-K
STAB
Statera Biopharma, Inc.
25 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
STAB
Statera Biopharma, Inc.
24 Mar 22
Statera Biopharma Announces Pricing of $5.7 Million Underwritten Public Offering
5:44pm
424B5
STAB
Statera Biopharma, Inc.
23 Mar 22
Prospectus supplement for primary offering
5:29pm
8-K
STAB
Statera Biopharma, Inc.
22 Mar 22
Entry into a Material Definitive Agreement
9:20am
424B5
STAB
Statera Biopharma, Inc.
22 Mar 22
Prospectus supplement for primary offering
7:34am
3
Satishchandran Chandrasekhar
21 Mar 22
Statera Biopharma / Satishchandran Chandrasekhar ownership change
7:27pm
8-K/A
STAB
Statera Biopharma, Inc.
8 Mar 22
Statera Biopharma Announces Revised Preliminary Revenue and Financial Results of Fiscal Year 2021
5:14pm
8-K
STAB
Statera Biopharma, Inc.
25 Feb 22
Statera Biopharma Announces Changes to Board of Directors
5:16pm